[INTERVENTIONAL GLAUCOMA - A SHIFT IN THE TREATMENT PARADIGM].

Harefuah Pub Date : 2024-05-01
Biana Dubinsky-Pertzov, Avner Belkin
{"title":"[INTERVENTIONAL GLAUCOMA - A SHIFT IN THE TREATMENT PARADIGM].","authors":"Biana Dubinsky-Pertzov, Avner Belkin","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Glaucoma is a progressive optic neuropathy and is the leading cause of preventable irreversible blindness worldwide. Glaucoma causes progressive visual field loss and can have significant implications on the patient's quality of life. Lowering intraocular pressure (IOP) is the only treatment proven to prevent vision loss from glaucoma. It is achieved using medication, laser treatment and surgery. The treatment paradigm of glaucoma has been one whereby surgical intervention has been left for advanced cases due to a variety of reasons, mainly concerning safety and long term success. The past two decades have seen a paradigm shift towards earlier IOP lowering interventions using a wide array of different technologies in the laser and surgical spaces. This review aims to understand the background to this paradigm shift, its necessity, and its potential impact on the vision and life of glaucoma patients.</p>","PeriodicalId":101459,"journal":{"name":"Harefuah","volume":"163 5","pages":"298-304"},"PeriodicalIF":0.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Harefuah","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Glaucoma is a progressive optic neuropathy and is the leading cause of preventable irreversible blindness worldwide. Glaucoma causes progressive visual field loss and can have significant implications on the patient's quality of life. Lowering intraocular pressure (IOP) is the only treatment proven to prevent vision loss from glaucoma. It is achieved using medication, laser treatment and surgery. The treatment paradigm of glaucoma has been one whereby surgical intervention has been left for advanced cases due to a variety of reasons, mainly concerning safety and long term success. The past two decades have seen a paradigm shift towards earlier IOP lowering interventions using a wide array of different technologies in the laser and surgical spaces. This review aims to understand the background to this paradigm shift, its necessity, and its potential impact on the vision and life of glaucoma patients.

[介入性青光眼--治疗模式的转变]。
引言青光眼是一种进行性视神经病变,是导致全球可预防的不可逆失明的主要原因。青光眼会导致渐进性视野缺损,并对患者的生活质量产生重大影响。降低眼压(IOP)是唯一被证明可以预防青光眼导致视力丧失的治疗方法。降低眼压的方法有药物治疗、激光治疗和手术治疗。由于种种原因,主要是安全性和长期成功率方面的原因,青光眼的治疗模式一直是将手术干预留给晚期病例。在过去的二十年里,治疗范式发生了转变,开始使用激光和手术领域的各种不同技术进行早期降低眼压干预。本综述旨在了解这种模式转变的背景、必要性及其对青光眼患者视力和生活的潜在影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信